Main Article Content
Aims: The aim of the work was to assess the efficacy of nebulized 3% hypertonic saline versus nebulized adrenaline in treatment of acute bronchiolitis in infants as supportive therapy with conventional therapy.
Place and Duration of Study: Pediatric Pulmonology Unit (PPU), Tanta University Hospital (TUH), was applied during the period from April 2019 to April 2020.
Methodology: We included ninety infants with moderate to severe acute bronchiolitis were selected, enrolled in the study and randomized into 3 groups: Group A: thirty patients were received nebulized 3% hypertonic saline plus conventional therapy. Was started from first day of admission till RADI score became 4. Group B: thirty patients were received nebulized adrenaline plus conventional therapy. Was started from first day of admission till RADI score became 4. Group C: thirty patients were received conventional therapy. Was started from first day of admission till RADI score became 4. They were subjected to history taking, clinical assessment and investigations (CXR, ECHO, CBC and CRP). Follow up done in Chest Clinic four day after discharge.
Results: There was statistically significant difference between studied groups as mean duration of O2 supplementation was significantly shorter in group B than in group A than in group C (p-value<0.05). On admission, mean RR in group B was significantly higher than those in groups A and C (p-value=0.05), On 5th day, mean RR in group B was significantly lower than those in groups A and C (p-value= 0.05). On admission, mean HR in group B was significantly higher than those in groups A and c (p-value =0.05) On 5th days, mean HR in group B was significantly lower than those in groups A and C (p-value= 0.05), with no statistically significant difference between groups A and C. length of hospitalization in studied groups group B showed significantly shorter need for hospital stay than that in groups A and C, with no statistically significant difference between group A and C.
Conclusion: When comparing between inhalation of adrenaline and hypertonic saline 3% in acute bronchiolitis adrenaline improve RD, oxygenation and decrease length of hospitalization.
Greenough A, Cox S, Alexander J, et al. Health care utilization of infants with chronic lung disease. Arch Dis Child. 2001;85:463-8.
Jha A, Jarvis H, Fraser C, et al. Respiratory syncytial virus. NCBI. 2017;5.
Abraha HY, Lanctot KL, Paes B. Risk of respiratory syncytial virus infection in preterm infants: Reviewing the need for prevention. Expert Review of Respiratory Medicine. 2015;9:779-99.
Zorc JJ, Hall CB. Bronchiolitis, recent evidence on diagnosis and management. Pediatric. 2010;125:342-9.
Sakulchit T, Goldman RD. Nebulized epinephrine for young children with bronchiolitis. Can Fam Physician. 2016;62:991–3.
Sit SP, Pal PS, Kant M, et al. Adrenaline versus salbutamol in infants with bronchiolitis. IOSR Journal of Dental and Medical Sciences. 2016;15:41-4.
Zhang L, Mendoza‐Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews. 2017;12:1858-465.
Grewal S, Ali S, McConnell DW, et al. A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med. 2009;163:1007-12.
O'Leary F, Hayen A, Lockie F, et al. Defining normal ranges and centiles for heart and respiratory rates in infants and children: A cross-sectional study of patients attending an Australian tertiary hospital paediatric emergency department. Archives of Disease in Childhood. 2015;100:733-7.
Verma IP, Garg P, Karnawat BS, et al. Study of therapeutic effects of nebulized adrenaline alone, nebulized adrenaline plus injectable dexamethasone (in combination) and nebulized 3% hypertonic saline alone in clinically diagnosed cases of bronchiolitis. International Journal Contemporay Pediatrics. 2017;4:1414- 9.
Asin F, Afridi ZS, Mahmood Q, et al. Role of nebulized epinephrine in moderate bronchiolitis: A quasi-randomized trial. Ir J. Med Sci.; 2020. DOI:https://doi.org/10.1007/s11845-020-02293-5
Del Giudice, Saitta F, Leonardi S, et al. Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis. International Journal of Immunopathology and Pharmacology. 2012;25:485-91.
Guo C, Sun X, Wang X, et al. Network meta‐analysis comparing the efficacy of therapeutic treatments for bronchiolitis in children. Journal of Parenteral and Enteral Nutrition. 2018;42:186-95.
Shanmuga Priyadharshini T. Comparison of nebulised adrenaline, nebulised salbutamol and nebulised budesonide in the treatment of bronchiolitis. A double blinded randomized trial. Doctoral Dissertation, Government Mohan Kumaramangalam Medical College, Salem; 2017.
Usman S, Zareen A, Gillani A, et al. Comparison of adrenaline and salbutamol nebulization in treatment of children with bronchiolitis. The Professional Medical Journal. 2019;26:1434-9.
Yasin F, Afridi ZS, Mahmood Q, et al. Role of nebulized epinephrine in moderate bronchiolitis: A quasi-randomized trial. Irish Journal of Medical Science. 2020;1: 4.
Florin TA, Plint AC, et al. Viral bronchiolitis. The Lancet. 2018;389:211-24. Iskander IF, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, e al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics. 2014;134(5): 1330-9.
Wainwright C, Zhang L, Mendoza‐Sassi RA, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews. 2017;12:1858-465.
Oymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2014;22:23.
Hsieh CW, Chen C, Chen KH, et al. Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: A meta-analysis of randomized controlled trials. BMC Pediatrics. 2020;20:434.